Meet the Beaten-Down Biotech Stock Cathie Wood Loves and Wall Street Says Could Rise More than 130%
Intellia Therapeutics is a Cathie Wood portfolio and has a high Wall Street valuation. The company’s top contenders look promising, but one of them just failed miserably. Intellia Therapeutics’ outlook looks very risky right now. 10 Stocks We Like More Than Intellia Therapeutics › Intellia Therapeutics (NASDAQ:NTLA)a small-cap biotech company, has some notable bulls. One … Read more